controversies in dialysis access (cida)

12
FEATURING LIVE CASES COURSE DIRECTORS Ingemar Davidson, M.D., Ph.D. Bart Dolmatch, M.D. CO-COURSE DIRECTOR Theodore Saad, M.D. PROGRAM ENCLOSED www.dialysiscontroversies.com October 11-12, 2012 PALMER HOUSE HILTON • CHICAGO, ILLINOIS DON’T MISS THE OPPORTUNITY TO WEIGH IN ON THE HARD-HITTING CONTROVERSIES SURROUNDING DIALYSIS ACCESS. The 9 th Annual SoDA SIMULATION of DIALYSIS ACCESS OCTOBER 10 Sponsored by

Upload: mdconferencefindercom

Post on 14-Jul-2015

482 views

Category:

Documents


4 download

TRANSCRIPT

Page 1: Controversies in Dialysis Access (CiDA)

FEATURING LIVE CASES

COURSE DIRECTORSIngemar Davidson, M.D., Ph.D.

Bart Dolmatch, M.D.

CO-COURSE DIRECTORTheodore Saad, M.D.

PROGRAM ENCLOSED

www.dialysiscontroversies.com

October 11-12, 2012PALMER HOUSE HILTON • CHICAGO, ILLINOIS

DON’T MISS THE OPPORTUNITY TO WEIGH IN ON THE HARD-HITTING CONTROVERSIES SURROUNDING DIALYSIS ACCESS.

The 9th Annual

SoDA

SIMULATION

of DIALYSIS ACCESS

OCTOBER 10

Sponsored by

Page 2: Controversies in Dialysis Access (CiDA)

A National Perspective without Limitations

Don’t miss the opportunity to weigh in on the hard-hitting controversies surrounding dialysis access.

The 9th Annual Controversies in Dialysis Access (CiDA) will set the stage for debates, discussions and a competitive challenge among interventional radiologists, vascular surgeons and nephrologists with the goal of improving patient care. A one-of-a-kind, highly interactive educational experience, CiDA invites each attendee to engage by sharing opinions and reacting to lectures through real-time audience polling and during question-and-answer sessions. Ideal for dialysis access veterans and beginners, CiDA 2012 will have attendees reassessing their approach, exploring innovative devices and contemplating techniques in the placement and management of dialysis access.

MEETING FEATURES

• Intensive Debates on Controversial Topics• Live Interventional Case Presentations• Case Reviews and Complications Sessions• Talks by Experienced Leaders in the Field• Interactive Real-time Polling of the Audience• Question-and-Answer Sessions that Cut to the Chase• It’s Access Academic: Clinical Game-show Style Challenge• Online Access to Course Presentations• Complimentary Journal Volume featurin

The 9th Annual

Page 3: Controversies in Dialysis Access (CiDA)

SPECIAL COMBO

DISCOUNT

SoDA and CiDA.

Register for both

meetings and save!

SIMULATION of DIALYSIS ACCESSOctober 10, 2012 | The Palmer House Hilton | Chicago, Illinois

An Optional Pre-course to CiDA 2012

SoDA COURSE DIRECTORS

Douglas Slakey M.D, Ph.D.New Orleans, Louisiana

Ingemar Davidson, M.D., Ph.D.Dallas, Texas

Bart Dolmatch, M.D.Dallas, Texas

SoDA FACULTY

Christine Hwang, M.D.Dallas, Texas

William Jennings, M.D.Oklahoma City, Oklahoma

Charmaine Lok, M.D.Toronto, Ontario

Elaine Meyer Ph.D.Boston, Massachusetts

Eric Peden, M.D.Houston, Texas

Mauro Pittiruti M.D.Rome, Italy

John Ross, M.D.Orangeburg, South Carolina

SoDA 2012Simulation of Dialysis Access (SoDA) will introduce physicians to new techniques in dialysis access through a variety of hands-on simulations. Expert lectures and panel discussions will complement the practical aspects of this unique and instructive meeting. SoDA promises an intensive examination of how simulation training can advance the field of dialysis access management. Through exploratory discussion, hands-on demonstrations and advice from leading experts, attendees will expand their skills and broaden their knowledge in an exciting, new way. For more information and to view the SoDa Scientific program please visit www.dialysiscontroversies.com.

Page 4: Controversies in Dialysis Access (CiDA)

CME INFORMATION

Learning ObjectivesUpon completion of this activity, the physician should be able to:• Understand and apply new algorithms for optimal patient selection for mode, location and type of dialysis access.• Choose the most appropriate surgical or interventional treatment options for dialysis access based on clinical trials, practice patterns and experience of thought leaders.• Identify and understand the controversial areas in dialysis access based on clinical data.• Make clinical care decisions based on current evidence and established patient care standards.

Target AudienceControversies in Dialysis Access will be of value to surgeons, interventional radiologists, nephrologists, and medical staff who care for dialysis access patients.

AccreditationComplete Conference Management is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit DesignationComplete Conference Management designates this live activity for a maximum of 14.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Note: According to the American Nurses Credentialing Center (ANCC), AMA PRA Category 1 CreditsTM

meet the ANCC-accredited CNE criteria.

DisclaimerThe information provided at this CME activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.

Faculty DisclosureIn accordance with ACCME Accreditation requirements, faculty are required to disclose any financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed during this educational activity and with any commercial supporters of this activity.

Page 5: Controversies in Dialysis Access (CiDA)

COURSE DIRECTORS Ingemar Davidson, M.D., Ph.D.Professor, Department of Surgery; University of Texas Southwestern Medical Center at DallasDallas, Texas

Bart Dolmatch, M.D.Professor, Department of Radiology;Director, Vascular and Interventional Radiology; University of TexasSouthwestern Medical Center at DallasDallas, Texas

CO-COURSE DIRECTOR

Theodore F. Saad, M.D.Interventional Nephrologist,Nephrology Associates, P.A.;Christiana Care Health SystemNewark, Delaware

INVITED FACULTY

Kenneth Abreo, M.D.Louisiana State UniversityBrooklyn, New York

Michael Allon, M.D.University of Alabama at BirminghamBirmingham, Alabama

Arif Asif, M.D.University of Miami School of MedicineMiami, Florida

Joanne Bargman, M.D.University Health NetworkToronto, Canada

Gerald Beathard, M.D., Ph.D.RMS LifelinePaige, Texas

Abigail Falk, M.D.American Access CareNew York, New York

Ziv Haskal, M.D.University of Maryland School of MedicineBaltimore, Maryland

Mitchell Henry, M.D.Ohio State UniversityColumbus, Ohio

Christine Hwang, M.D.University of Texas Southwestern Medical Center of DallasDallas, Texas

Karl Illig, M.D.University of Rochester Medical CenterRochester, New York

William Jennings, M.D.University of OklahomaOklahoma City, Oklahoma

Brian LaMendola, R.N., B.S.N.Vascular Access Centers, LLPBridgeville, Pennsylvania

Charmaine Lok, M.D.University of TorontoToronto, Ontario

Gregg Miller, M.D.Columbia UniversityBrooklyn, New York

Jeffery Packer, D.O.Arizona Kidney Disease & Hypertension CentersPhoenix, Arizona

Biff Palmer, M.D.University of Texas Southwestern Medical CenterDallas, Texas

Eric Peden, M.D.Methodist DeBakeyHeart & Vascular CenterHouston, Texas

Dheeraj Rajan, M.D.Toronto General HospitalToronto, Ontario

John Ross, M.D.Bamberg County HospitalBamberg, South Carolina

Douglas Slakey, M.D.Tulane UniversityNew Orleans, Louisiana

Lawrence Spergel, M.D.University of CaliforniaSan Francisco, California

Scott Trerotola, M.D.University of Pennsylvania Medical CenterPhiladelphia, Pennsylvania

Thomas Vesely, M.D.Vascular Access Services, LLCSaint Louis, Missouri

Jay Wish, M.D.Case Western Reserve University School of MedicineUniversity Hospital’s Case Medical CenterCleveland, Ohio

Jack Work, M.D.Emory UniversityAtlanta, Georgia

ADJUNCT FACULTY Dirk Hentschel M.D. Brigham and Women’s HospitalBoston, Massachusetts

Peter H. Wayne III, M.D. Norton Audubon Vascular Access Center at Norton Health Care Louisville, Kentucky

Page 6: Controversies in Dialysis Access (CiDA)

CIDA 2012 SCIENTIFIC PROGRAMDay 1: October 11

Session I Initiation of Dialysis Moderators: Drs. Davidson and Dolmatch

7:30 a.m. The “When, Why, What, Who and How” of Dialysis Access Drs. Davidson, Dolmatch, Ross

7:45 a.m. Timing of Dialysis Access: When Does the ESRD Patient Need to Initiate Dialysis?

Dr. Palmer

7:55 a.m. Peritoneal Dialysis: Why It’s the Best Dialysis, and What’s Being Done to Increase Acceptance

Dr. Bargman

DEBATE: Taking a Stand on PD Catheter Placement 8:05 a.m. Fluoroscopic/Peritoneoscopic Guided PD Catheter Placement:

Patient Selection and OutcomesDr. Abreo

8:11 a.m. Laparoscopically Guided PD Catheter Placement: Patient Selection and Outcomes

Dr. Slakey

8:17 a.m. Surgically Placed PD Catheters: Patient Selection and Outcomes

Dr. Hwang

8:23 a.m. Around CiDA’s Table: PD Catheter Placement Options: Is There a “Best Practice?”

Drs. Abreo, Bargman, Hwang, Palmer, Slakey

8:35 a.m. CiDA’s on the Case #1: The Malfunctioning PD Catheter: What’s Wrong, Why Did it Happen, and How Can it be Fixed?

Moderator: Dr. Dolmatch Panelists: Drs. Abreo, Bargman, Hwang, Palmer, Slakey

9:00 a.m. Tunneled Dialysis Catheters for Initiation of Hemodialysis: What’s the Problem?

Dr. Work

9:08 a.m. Why are Catheters Still the Predominant Initial HD Access in the U.S. and What Effectively Reduces Their Use?

Dr. Wish

9:16 a.m. CiDA’s on the Case #2: TDC or Not? Case-based Application of TDC Avoidance Strategies

Moderator: Dr. Dolmatch Panel: Drs. Bargman, Slakey, Wish, Work

9:40 a.m. Refreshment Break and Visit Exhibits

Session II The Best Access for Every Patient Moderators: Drs. Davidson and Lok

10:00 a.m. The Fistula First Initiative: Old News or New Hope? Dr. Spergel

10:08 a.m. Vascular Evaluation and Decisions for Access in Diabetic Patients: Anything Different?

Dr. Allon

10:16 a.m. AVF Timing: Should Pre-emptive AVF’s Be Created in High Risk Patients

Dr. Lok

DEBATE: Are We Getting Any Better at Selecting the “Best” Dialysis Access for Our Patients?

10:24 a.m. For ESRD Patients, an AVF Should Always Be Considered First Dr. Spergel

10:30 a.m. An AVF, When Possible, Is not Always in the Patient’s Best Interest Dr. Davidson

10:36 a.m. Discussion Drs. Spergel, Allon, Lok, and Davidson

Session III: A Smorgasbord of Interesting Topics Moderators: Drs. Vesely and Beathard10:46 a.m. Upper Arm AV Access: Brachiobasilic AVF, Brachiocephalic

AVF, or AVG - What’s Most Durable?Dr. Work

10:54 a.m. Thigh Access: Options, Outcomes and Controversies Dr. Allon

11:02 a.m. Those Little Yellow Things that are Sold to Keep Catheters from Clotting and Getting Infected

Dr. Hentschel

11:10 a.m. Concensus in Dialysis Access: Terms and Definitions - Do They Matter and Can We Agree?

Dr. Vesely

11:18 a.m. Lies, More Lies, and Then There Are Statistics: Can Non-inferiority Studies Ever Show Superiority? and Other Basic Concepts

Dr. Beathard

11:26 a.m Around CiDA’s Table: Dining at the Smorgasbord Drs. Work, Allon, Hentschel, Vesely, Beathard, Work

11:35 a.m. CiDA’s on the Case #3: Whatever Happened to Patients from Past CiDA Case Sessions?

Moderator: Dr. Dolmatch Panel: Drs. Allon, Hentschel, Vesely, Work

12:00 p.m. Lunch and Visit Exhibits

CiDA Clinic Sessions (Attendee’s Choice)

1:10 p.m. 1. Surgical Techniques for Creation of AV Access: How I Do It Moderator: Dr. Davidson Panelists: Drs. Jennings, Packer, Slakey, Spergel

Page 7: Controversies in Dialysis Access (CiDA)

1:10 p.m. 2. Endovascular Techniques to Maintain AVF’s and AVG’s: Moderator: Dr. Dolmatch How I Do It Panelists: Drs. Abreo, Saad, Trerotola, Urbanes 1:10 p.m. 3. Practical Aspects of Delivering PD and HD: The Devil Is in the Moderator: Dr. Bargman Details Panelists: Drs. LaMendola, Allon, Palmer, Work, Wish

Session IV The Best Strategies to Maintain Access Moderators: Drs. Dolmatch and Allon

2:00 p.m. AV Access Surveillance and Monitoring: What’s Expected and How’s It Really Being Done in the U.S.?

Dr. Abreo

2:08 p.m. AV Access Flow Measurements - When Are They Abnormal and What Should Be Done?

Dr. Vesely

2:16 p.m. Is There Value to an Elective Fistulogram After Previous AV Access Intervention?

Dr. Miller

2:24 p.m. Hyperkalemia Waltz Warning: Why did it Occur, What are the Manifestations, Which Treatment is Best, When to Proceed?

Dr. Palmer

2:32 p.m. Safe and Effective Use of CO2 for Fistulography Dr. Wayne

2:40 p.m. Around CiDA’s Table: Panel Discussion Panelists: Drs. Abreo, Vesely, Miller, Palmer, Wayne

2:50 p.m. Refreshment Break and Visit Exhibits

3:10 p.m. Post-market Clinical Trial Results of an FDA-approved Stent Graft for AVG Venous Anastomotic Stenosis.

Dr. Haskal

3:18 p.m. Stent Grafts for Salvage of PTA: Outcome in 106 Patients Dr. Dolmatch

3:26 p.m. Stent Grafts in AV Access: Is There Madness to the Method? Dr. Trerotola

3:34 p.m. Around CiDA’s Table: Stent-grafts: Where Do They Fit in AV Access Maintenance?

Drs. Beathard, Vesely, Trerotola, Haskal, LaMendola

3:45 p.m. CiDA’s on the Case #4: Failed PTA. Options and Outcomes Moderator: Dr. Dolmatch Panelists: Drs. Vesely, Trerotola, Beathard, Haskal, Packer

Day 1: October 11 (Continued)

4:20 p.m. It’s Access Academic: Can’t Anyone Beat the IR Team? Moderator: Dr. Dolmatch

2010 & 2011 REIGNING CHAMPS

The Interventional Radiologists Drs. Falk, Haskal, Trerotola

The SurgeonsDrs. Henry, Jennings, Spergel

THE TEAMS

The Nephrologists Drs. Palmer, Lok, Wish

5:00 p.m. Adjourn for the Day

Its Access Academic

Page 8: Controversies in Dialysis Access (CiDA)

Session V Next Generation Access Updates and CiDA LIVE Moderators: Drs. Davidson and Dolmatch

7:30 a.m. Daily Welcome and Introduction to Live Case Presentations Drs. Davidson and Dolmatch

7:40 a.m. The Hybrid AV Graft: Clinical Experience Dr. Henry

7:48 a.m. AV Fistulae Cannulation Windows: Clinical Trial Update Dr. Jennings

7:56 a.m. Early Cannulation Arteriovenous Grafts Dr. Peden

8:04 a.m. Creation of AVF’s Under Conscious Sedation and Local Anesthesia

Dr. Packer

8:12 a.m. CiDA LIVE Case #1 Operator: Dr. Ross Panelists: Drs. Henry, Jennings, Peden, Packer

Session VI Central Venous Obstruction Moderators: Drs. Saad and Illig

8:40 a.m. Central Venous Occlusion Anatomy and Etiology in the Dialysis Patient: Begging for Clarity

Dr. Illig

8:48 a.m. An Honest Reappraisal of PTA and Stents for Central Venous Obstruction

Dr. Rajan

8:56 a.m. Surgical Decompression for Central Venous Obstruction Dr. Illig DEBATE: Transvenous CIED Leads

9:04 a.m. Transvenous CIED Leads are Disasterous for CKD/ESRD Patients - Place Epicardial Leads

Dr. Asif

9:10 a.m. Transvenous CIED Leads May Not Be so Bad After All - Epicardial Leads Aren’t the Answer

Dr. Saad

9:16 a.m. Transvenous Versus Epicardial Leads - What’s the Solution? Drs. Asif, Illig, Rajan, Saad

9:26 a.m. CiDA LIVE Case #2 Operator: Dr. Ross

Panelists: Drs. Illig, Rajan, Asif, Saad

10:00 a.m. Refreshment Break and Visit Exhibits

Session VII Distal Hypoperfusion Ischemia Syndrome (DHIS) Moderators: Drs. Davidson and Henry

10:20 a.m. DHIS: Defintions, Causes, Measurements and Clinical Presentations

Dr. Henry

10:28 a.m. Surgery for DHIS: DRIL, PAI, or Banding: When to Do What, and How Do You Know It Worked?

Dr. Jennings

10:36 a.m. Percutaneous Management of DHIS: Beyond the Miller Procedure

Dr. Packer

10:42 a.m. Around CiDA’s Table: DHIS - Diagnosis and Management Drs. Henry, Jennings, Miller, Packer

10:50 a.m. CiDA LIVE Case #3 Operator: Dr. Ross

Panelists: Drs. Henry, Jennings, Packer, Miller

Session VIII Aneurysmal AVF’s Moderators: Drs. Peden and Davidson

11:25 a.m. AVF Aneurysms -Cause for Concern or Just Ugly? Dr. Peden

11:33 a.m. Do Most Aneurysmal AVF’s Have Associated Central Stenoses?

Dr. Rajan

11:41 a.m. Aneurysmorrhaphy for Preservation of the Mega AVF - How I Do It

Dr. Davidson

11:49 a.m. Discussion on Aneurysmal AVF Panel Discussion: Drs. DavidsonJennings, Peden, Rajan

CIDA 2012 SCIENTIFIC PROGRAMDay 2: October 12

Page 9: Controversies in Dialysis Access (CiDA)

12:00 p.m. Lunch and Visit Exhibits

CiDA CLINIC SESSIONS

(Attendee’s Choice)

1:15 p.m. 1. Technical Considerations in Treating the Clotted AV Access Moderator: Dr. Falk

Panelists: Drs. Haskal, Miller, Rajan

1:15 p.m. 2. Technical Considerations in Symptomatic Central Vein Obstruction

Moderator: Dr. Dolmatch

Panelists: Drs. Asif, Illig, Peden, Vesely

2:00 p.m. Refreshment Break and Visit Exhibits

2:20 p.m. CiDA LIVE Case #4 Operator: Dr. Ross

Panelists: Drs. Davidson, Henry, Illig, Packer, Wish

Session IX The Clotted AV Access Moderators: Drs. Asif and Dolmatch

3:00 p.m. AVF Declotting: What’s New? Dr. Falk

3:08 p.m. Update on Patency Following AVF Declotting Dr. Beathard

DEBATE: A “Good” 3-week-old AVF Just Clotted Yesterday

3:16 p.m. It’s Worth DeclottingDr. Asif

3:22 p.m. Don’t Bother Dr. Trerotola

3:28 p.m. Panel Discussion: When to Abandon a Thrombosed AVF Drs. Asif, Falk, Beathard, Trerotola

3:40 p.m. CiDA LIVE Case #5 Operator: Dr. Ross

Panelists: Drs. Falk, Rajan, Trerotola, Miller, Work

4:15 p.m. Awards and Final Thoughts Drs. Davidson and Dolmatch

4:30 p.m. Symposium Adjourn

Day 2: October 12 (Continued)

Page 10: Controversies in Dialysis Access (CiDA)

ACCOMMODATIONS The Palmer House Hilton17 East Monroe StreetChicago, Illinois 60603Reservations: 1-800-HILTONS (1-800-445-8667)Special Meeting Rate: $255

The legendary Palmer House hotel is synonymous with Chicago’s rich history. Conveniently located in downtown, hotel guests will be within walking distance of downtown shops, architectural landmarks and national attractions.

To obtain the special meeting rate, please identify yourself as a participant of the 9th Annual CiDA (Controversies in Dialysis Access) meeting when reserving your room. The deadline to reserve rooms at the discounted rate is Tuesday, September 25, 2012, or until available discounted rooms have been reserved, whichever comes first. For information about sporting events, area attractions, dining options and more, please visit www.explorechicago.org

Registration Type

PhysicianFellow/Resident*Allied Health Professional(Nurse, Nurse Practitioner, Technologist,

Physician Assistant, Current Student)

Industry Professional, Scientist, Engineer

*Fellow/Resident: A letter of fellowship status from your program director is required in order to qualify for reduced fee. Please fax letter to 305-279-8221 or email to [email protected].

CiDA & SoDA Combo

October 10-12

CiDA Course October 11-12

SoDA Course October 10

$849 $624 $624

$849

$650 $425 $425

$650

$249 $249 $249

$249

REGISTRATION INFORMATION

5 EASY WAYS TO REGISTER Online www.dialysiscontroversies.com Fax 305-279-8221 Email [email protected] Phone US & Canada 888-334-7495 | International 305-279-2263 Mail Please use the enclosed registration form and send check payment to: Complete Conference Management 11440 N. Kendall Drive, Suite 306, Miami, FL 33176

QUESTIONS

Telephone: U.S. and Canada 888-334-7495 | International 305-279-2263Fax: 305-279-8221E-mail: [email protected]: www.ccmcme.com

Page 11: Controversies in Dialysis Access (CiDA)

Pre-registration deadline is October 4, 2012, at 11:59 PM EST. Registration will reopen onsite. First Name: Last Name: Designation: MD DO PhD PA BSN LPN NP RN RT RT(R) RVT CVT Other: Home Address: City: State: Postal Code: Country: Medical Center/Hospital/Company: Daytime Phone: Mobile Phone: E-mail Address (Required to receive confirmation & certificate information): Pursuant to the Americans with Disabilities Act, please specify any special services you require: State(s) of ProfessionalLicensure: License Number:

2012 REGISTRATION FORM

Cardiothoracic Surgery General Nephrology General Radiology General Surgery Interventional Nephrology Interventional Radiology Transplant Surgery Vascular Surgery Other Surgery Other ____________

Administrative Support Staff Nurse Practitioner Physician Assistant Registered Nurse Radiologic Technologist Registered Radiologic Technologist Cardiovascular Technologist Registered Vascular Technologist Other _______________

Industry Professional Engineer Scientist Other __________________

SPECIALTY/REGISTRATION TYPE (Please select only one)

PHYSICIAN ALLIED HEALTH PROFESSIONAL INDUSTRY/NON-CLINICAL

CLINICAL SESSIONS (Please choose only one per day.)

Thursday, October 11 Surgical Techniques for Creation of AV Access: How I Do It Practical Aspects of Delivering PD and HD: The Devil Is in the Details Endovascular Techniques to Maintain AVF’s and AVG’s: How I do it Friday, October 12 Technical Considerations in Treating the Clotted AV Access Technical Considerations in Symptomatic Central Vein Obstruction

Onsite registration will incur an additional $45 administrative fee

CiDA & SoDA ComboOctober 10-12

CiDA CourseOctober 11-12

SoDA Course OnlyOctober 10

Fellow/Resident: A letter of fellowship status from your program director is required in order to qualify for reduced fee. Please fax letter to 305-279-8221 or you may e-mail your letter to [email protected].

Physician*Fellow/ResidentAllied Health ProfessionalIndustry Professional, Scientist, Engineer

$849 $624 $624 $849

$650 $425 $425 $650

$249 $249 $249 $249

REGISTRATION FEES

Which of these contributed to your decision to register for the upcoming meeting? (Check all that apply)

Mailing Code Age Group

Under 30 30-40 41-50 51-60 61 and over

If you received a mailed postcard or brochure, please provide the 3 or 4 letter code found above your name on the address label:

DEMOGRAPHIC INFORMATION

Colleague/Institution Journal Advertisement Email/Electronic Newsletter Mailed Postcard/Brochure Flyer at Other Meetings I am a Past Attendee Other (Please specify)

PAYMENT INFORMATION Visa MasterCard American Express Check (To: Complete Conference Management) Card Number: Expiration Date: Security Code: Name on card: Card Billing Address:

Authorized Signature: Date: Total Charge/Enclosed:

CANCELLATION POLICY: Cancellation requests in writing on or before September 20, 2012, will be honored, less a $50 administrative fee. Requests received after September 20, 2012, will not be honored.

This educational activity provides training necessary for licensed attendees to maintain state licensing requirements. The tuition for this educational activity is subsidized in part by unrestricted educational grants, including for those attendees who have successfully completed the state licensing requirements for their respective fields. This subsidy is reflected in the registration fees for this activity.

(As continuing education providers, it is important to our recordkeeping process to maintain information relating to our learners’ licensure. To that end, providing your professional license number is optional, but of importance to continuing education efforts.)

Page 12: Controversies in Dialysis Access (CiDA)

Oct

ober

11-

12, 2

012

PALM

ER

HO

US

E H

ILTO

N •

CH

ICA

GO

, ILL

INO

IS

Com

ple

te C

onfe

renc

e M

anag

emen

t11

440

N. K

end

all D

rive,

Sui

te 3

06M

iam

i, FL

331

76

PRSR

T ST

DU

.S. P

osta

gePA

IDPe

rmit

#246

4M

iam

i, Fl

orid

a

CO

NTR

OV

ER

SIE

S IN

DIA

LYS

IS A

CC

ES

SA

Nat

iona

l Per

spec

tive

with

out

Lim

itatio

ns

ME

ET

ING

FE

ATU

RE

S

• In

tens

ive

Deb

ates

on

Con

trov

ersi

al T

opic

s•

Live

Inte

rven

tiona

l Cas

e P

rese

ntat

ions

• C

ase

Rev

iew

s an

d C

omp

licat

ions

Ses

sion

s•

Talk

s b

y E

xper

ienc

ed L

ead

ers

in t

he F

ield

• In

tera

ctiv

e R

eal-

time

Pol

ling

of t

he A

udie

nce

• Q

uest

ion-

and

-Ans

wer

Ses

sion

s th

at C

ut t

o th

e C

hase

• It’

s A

cces

s A

cad

emic

: Clin

ical

Gam

e-sh

ow S

tyle

Cha

lleng

e•

Onl

ine

Acc

ess

to C

ours

e P

rese

ntat

ions

• C

omp

limen

tary

Jou

rnal

Vol

ume

feat

urin

g C

iDA

Ab

stra

cts

Bac

k B

y P

opu

lar

Dem

and

!S

oDA

Sim

ulat

ion

of D

ialy

sis

Acc

ess

A o

ne-o

f-a-

kind

han

ds-

on s

imul

atio

n op

por

tuni

tyaw

aits

you

at

SoD

A o

n O

ctob

er 1

0, 2

012.

S

ee p

age

2.